Grand Rounds October 20, 2023: A National Initiative to Eliminate Hepatitis C in the United States – Why This Matters to Clinical Trialists (Rachael L. Fleurence, PhD, MSc; Joshua M. Sharfstein, MD)
Rethinking Clinical Trials
OCTOBER 26, 2023
point of care diagnostic tests, provide broad access to curative Hepatitis C medications with a national subscription model, with Medicare co-pay assistance and commercial insurance coverage. with the rate of reported acute Hepatitis C cases increasing 400% during 2010-2020. The initiative would bring to the U.S.
Let's personalize your content